KIMS Hospitals Reports Strong Revenue Growth Amid Profit Decline
Krishna Institute of Medical Sciences Ltd announced its financial results for the fourth quarter and full year ending March 31, 2026. The company achieved a total revenue of INR 1,084 crore for Q4 FY26, a 35.3% increase from the previous year and an 8.1% rise from the previous quarter. For the full fiscal year FY26, total revenue reached INR 3,931 crore, up 28.2% year-over-year.
Despite the robust top-line performance, profitability metrics showed a significant downturn. Q4 FY26 EBITDA rose only 6.8% year-on-year to INR 216 crore, while Profit After Tax (PAT) plummeted 69% to INR 33 crore. For the full fiscal year FY26, EBITDA grew a marginal 1.6% to INR 828 crore, and PAT fell 41.7% to INR 242 crore. Consolidated Earnings Per Share (EPS) also declined by 37.2% to INR 6.03.
Expansion Costs Hit Profitability
The significant revenue growth highlights KIMS Hospitals' successful expansion and increased patient volume across its network. However, the sharp decline in PAT and EBITDA margins indicates that the costs associated with opening and ramping up new hospital units are impacting profitability. New units contributed INR 224 crore in revenue but also INR 32 crore in EBITDA erosion during Q4 FY26. For the full year, new units resulted in an EBITDA loss of INR 128 crore, a figure the company expects to reduce by more than half in FY27.
Debt Reduction and Strategic Consolidation
KIMS Hospitals plans to raise INR 1,500 crore through a Qualified Institutions Placement (QIP). The primary goal of this fundraising is to retire debt, which has surpassed INR 3,000 crore. The company also intends to pursue small acquisition opportunities and focus on consolidating its existing hospitals to improve margins.
Key Risks and Future Focus
Key risks for KIMS Hospitals include the continuing drag on EBITDA from new facilities, potential delays in insurance empanelment affecting the ramp-up of new units, and intense competition, particularly in markets like Hyderabad. While the QIP aims to reduce debt, the company's overall debt levels remain a point of attention. Investors will be closely watching the progress of the QIP, debt reduction efforts, and the profitability of newly established hospital units. The company targets a net debt to EBITDA ratio of 1:2 from the current 1:3.
